What patient factors commonly necessitate chemotherapy dose adjustments?

• A. Renal or hepatic impairment, performance status, age, pregnancy, and drug interactions.
• B. Dietary preferences and BMI.
• C. Hair color and eye color.
• D. Time of day and weather.

Answer: (A)

Chemotherapy dosing must be tailored to patient-specific factors that influence how a drug is cleared from the body and how toxic it will be. When kidneys aren’t clearing drugs well, or the liver isn’t metabolizing them efficiently, drug exposure can rise and toxicity can increase, so doses or dosing schedules are adjusted based on renal or hepatic function tests (like creatinine clearance/eGFR and liver enzymes or bilirubin). A patient’s overall ability to handle treatment, often captured by performance status, also guides dosing because frailer or less functional patients are at higher risk for severe side effects, which can necessitate starting at lower doses or modifying the regimen.

Age plays a role because very young or older patients may have different organ function or sensitivities, altering risk of toxicity and sometimes requiring dose tweaks. Pregnancy is another critical factor since many chemotherapies can harm a developing fetus; dosing decisions here balance maternal treatment needs with fetal safety, often leading to avoidance or significant modification of certain drugs and timing. Drug interactions matter because concomitant medications can change how a chemo agent is metabolized or increase overlapping toxicities, prompting dose reductions or changes to the regimen to maintain safety.

Dietary preferences or BMI, hair and eye color, or considerations like time of day and weather don’t directly dictate standard dose adjustments in the same way, so they’re not the factors used to modify chemotherapy dosing.